🇺🇸 FDA
Pipeline program

Zr89

Phase 2 small_molecule active

Quick answer

Zr89 for giant cell arteritis, rheumatoid arthritis is a Phase 2 program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
giant cell arteritis, rheumatoid arthritis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials